These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6141645)

  • 1. Shortterm "escape" and longterm "drift." The dissipation effects of the beta adrenergic blocking agents.
    Boger WP
    Surv Ophthalmol; 1983 Dec; 28 Suppl():235-42. PubMed ID: 6141645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans.
    Gandolfi SA; Vecchi M
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):684-8. PubMed ID: 8595970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timolol in the therapy of "ocular hypertension".
    Boger WP; Steinert RF; Thomas JV
    Surv Ophthalmol; 1980; 25(3):195-202. PubMed ID: 6110245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the beta-adrenergic receptor-binding agent 'timolol' in the treatment of open-angle glaucoma.
    Strempel I
    Ophthalmologica; 1982; 184(4):198-203. PubMed ID: 6122193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the intraocular pressure-lowering effect of 0.5% timolol maleate and the docosanoid derivative of a PGF2 alpha metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension.
    Nordmann JP; Rouland JF; Mertz BP
    Curr Med Res Opin; 1999; 15(2):87-93. PubMed ID: 10494491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma.
    Konstas AG; Maltezos AC; Gandi S; Hudgins AC; Stewart WC
    Am J Ophthalmol; 1999 Jul; 128(1):15-20. PubMed ID: 10482089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian intraocular pressure and blood pressure reduction with timolol 0.5% solution and timogel 0.1% in patients with primary open-angle glaucoma.
    Quaranta L; Katsanos A; Floriani I; Riva I; Russo A; Konstas AG
    J Clin Pharmacol; 2012 Oct; 52(10):1552-7. PubMed ID: 22110164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Michaud JE; Friren B;
    Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of orally and topically administered beta blockers for chronic simple glaucoma.
    Williamson J; Young JD; Atta H; Muir G; Kadom H
    Br J Ophthalmol; 1985 Jan; 69(1):41-5. PubMed ID: 2856893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group.
    García Sanchez J
    Eur J Ophthalmol; 2000; 10(3):198-204. PubMed ID: 11071026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma.
    Konstas AG; Stewart WC; Topouzis F; Tersis I; Holmes KT; Stangos NT
    Am J Ophthalmol; 2001 Jun; 131(6):729-33. PubMed ID: 11384568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinico-pharmacological study of an ophthalmic drug form of proxodolol].
    Ermakova VN
    Eksp Klin Farmakol; 1994; 57(3):57-9. PubMed ID: 7914124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ocular pulse amplitude, intraocular pressure and beta blocker/carbonic anhydrase inhibition in combined therapy of primary open-angle glaucoma].
    Schmidt KG; von Rückmann A; Becker R; Pillunat LE
    Klin Monbl Augenheilkd; 1999 Dec; 215(6):361-6. PubMed ID: 10637801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%.
    Orengo-Nania S; Landry T; Von Tress M; Silver LH; Weiner A; Davis AA;
    Am J Ophthalmol; 2001 Dec; 132(6):860-8. PubMed ID: 11730649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dorzolamide/timolol and latanoprost/timolol fixed combinations on diurnal intraocular pressure control in primary open-angle glaucoma.
    Eren MH; Gungel H; Altan C; Pasaoglu IB; Sabanci S
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):381-6. PubMed ID: 22320418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of timoptic depot in hypotensive therapy of glaucoma].
    Erichev VP; Iakubova LV
    Vestn Oftalmol; 1998; 114(1):8-9. PubMed ID: 9584629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined therapy in glaucoma treatment: travoprost 0.004% and brinzolamid].
    Popović Suić S; Vukojević N; Cerovski B; Jukić T
    Acta Med Croatica; 2006; 60(2):101-3. PubMed ID: 16848197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dorzolamide timolol combination versus timolol 0.5% on ocular bloodflow in patients with primary open-angle glaucoma.
    Harris A; Jonescu-Cuypers CP; Kagemann L; Nowacki EA; Garzozi H; Cole C; Martin B
    Am J Ophthalmol; 2001 Oct; 132(4):490-5. PubMed ID: 11589868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.